Abingem 1gm (Gemcitabine Vials) 1gm

Abingem 1gm is a prescription chemotherapy medication containing gemcitabine, supplied in 1gm vials for intravenous use. It is commonly used in cancer treatment protocols to manage solid tumors. Store at room temperature away from moisture and heat.

Strength

1gm

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Miraculus Pharma Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine, the active ingredient in Abingem 1gm, is used to treat various types of cancer including pancreatic, lung, bladder, and breast cancer. It works by slowing or stopping cancer cell growth. This medication is typically administered under medical supervision as part of a chemotherapy regimen. Patients often ask, what is gemcitabine used for and how does it fit into cancer treatment plans.

Side Effects

Abingem 1gm may cause side effects such as nausea, fatigue, or flu-like symptoms during treatment. Some patients experience hair thinning or changes in blood cell counts, which are monitored regularly. These effects vary by individual and treatment duration.

Precautions & Warnings

Handle Abingem 1gm vials with care to avoid contamination or spills. Use protective gloves and dispose of vials properly after use. Keep out of reach of children and pets. Inform your healthcare provider about any pre-existing conditions or allergies before starting treatment.

Avoid Interactions

Gemcitabine may interact with other medications, including certain antibiotics, antivirals, or drugs affecting the liver. Alcohol and herbal supplements should be used cautiously. Always disclose all medications and supplements to your doctor to minimize risks.

Frequently Asked Questions

Gemcitabine is primarily used to treat various cancers, including pancreatic, lung, bladder, and breast cancer.

Abingem 1gm is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects may include nausea, fatigue, flu-like symptoms, or changes in blood cell counts.

Gemcitabine may interact with other drugs; consult your doctor before combining medications.

Store vials at room temperature, away from moisture and heat, and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.